BioSyent Inc. (TSXV:RX)
14.63
+0.22 (1.53%)
Apr 8, 2026, 11:04 AM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 165.71 million as of April 8, 2026. Its market cap has increased by 36.21% in one year.
Market Cap
165.71M
Enterprise Value
137.90M
Revenue
43.05M
Ranking
n/a
PE Ratio
18.40
Stock Price
14.63
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 165.71M, an increase of 1,154.87%. That is a compound annual growth rate of 9.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 165.71M | 15.59% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TerrAscend | 288.85M |
| Aurora Cannabis | 271.64M |
| Organigram Global | 261.77M |
| Cardiol Therapeutics | 219.66M |
| Auxly Cannabis Group | 182.66M |
| Cannara Biotech | 175.83M |
| Charlotte's Web Holdings | 162.88M |
| HLS Therapeutics | 137.60M |